אטורבסטאטין טבע ® 40 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ATORVASTATIN AS CALCIUM 40 MG

MAH:

TEVA PHARMACEUTICAL INDUST.LTD

ATC_code:

C10AA05

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

therapeutic_group:

ATORVASTATIN

therapeutic_indication:

Atorvastatin Teva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Atorvastatin Teva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable. Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. LDL

authorization_date:

2010-05-01